Analysis of the association between CIMP and BRAFV600Ein colorectal cancer by DNA methylation profiling

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Hinoue, Toshinori ^a,b   Weisenberger, Daniel J ^a   Pan, Fei ^a   Campan, Mihaela ^b   Kim, Myungjin ^b   Young, Joanne ^c,d   Whitehall, Vicki L ^e   Leggett, Barbara A ^e   Laird, Peter W ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BONE MORPHOGENETIC PROTEIN 6; EPHRIN RECEPTOR A3; GLUTAMIC ACID; OSTEOGENIN; SMOOTHENED PROTEIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; UNCLASSIFIED DRUG; VALINE; VASCULOTROPIN RECEPTOR 1; BRAF PROTEIN, HUMAN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN RELATED PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; MESSENGER RNA; MUTANT PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL AGING; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; PHENOTYPE; PROMOTER REGION; SIGNAL TRANSDUCTION; WILD TYPE; CELL CLONE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; TUMOR CELL LINE; TUMOR GENE;

ERINACEIDAE;

CELL LINE, TUMOR; CLONE CELLS; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, NEOPLASM; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MUTANT PROTEINS; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS B-RAF; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 77249141762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008357     Document Type: Article

References (53)

1. Jones PA, Baylin SB (2007) The epigenomics of cancer. Cell 128: 683-692.
2. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96: 8681-8686.
3. Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4: 988-993.
4. Yamashita K, Dai T, Dai Y, Yamamoto F, Perucho M (2003) Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4: 121-131.
5. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793.
6. O'Brien MJ (2007) Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 36: 947-68, viii.
7. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, et al. (2005) Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129: 837-845.
8. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV et al (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53: 1137-1144.
9. Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, et al. (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55: 1467-1474.
10. Rosenberg DW, Yang S, Pleau DC, Greenspan EJ, Stevens RG, et al. (2007) Mutations in BRAF and KRAS differentially distinguish serrated versus non- serrated hyperplastic aberrant crypt foci in humans. Cancer Res 67: 3551-3554.
11. Oliveira C, Westra JL, Arango D, Ollikainen M, Domingo E, et al. (2004) Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status. Hum Mol Genet 13: 2303-2311.
12. Garnett MJ, Marais R (2004) Guilty as charged: B-RAF is a human oncogene. Cancer Cell 6: 313-319.
13. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
14. Haigis KM, Wistuba II, Kurie JM (2007) Lung premalignancy induced by mutant B-Raf, what is thy fate? To senesce or not to senesce, that is the question. Genes Dev 21: 361-366.
15. Bibikova M, Chudin E, Wu B, Zhou L, Garcia EW, et al. (2006) Human embryonic stem cells have a unique epigenetic signature. Genome Res 16: 1075-1083.
16. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, et al. (2006) High- throughput DNA methylation profiling using universal bead arrays. Genome Res 16: 383-393.
17. Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken RH, Webster MJ, et al. (2007) DNA methylation signatures within the human brain. Am J Hum Genet 81: 1304-1315.
18. Houseman EA, Christensen BC, Yeh RF, Marsit CJ, Karagas MR, et al. (2008) Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics 9: 365.
19. TCGA-Consortium (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
20. Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, et al. (2009) A microarray-based DNA methylation study of glioblastoma multiforme. Epige- netics 4: 255-264.
21. Bibikova M, Fan JB (2009) GoldenGate(R) Assay for DNA Methylation Profiling. Methods Mol Biol 507: 149-163.
22. Byun HM, Siegmund KD, Pan F, Weisenberger DJ, Kanel G, et al. (2009) Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. Hum Mol Genet 18: 4808-4817.
23. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, et al. (2009) Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5: e1000602.
24. Katari S, Turan N, Bibikova M, Erinle O, Chalian R, et al. (2009) DNA methylation and gene expression differences in children conceived in vitro or in vivo. Hum Mol Genet 18: 3769-3778.
25. Loh K, Chia JA, Greco S, Cozzi SJ, Buttenshaw RL, et al. (2008) Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes Cancer 47: 449-460.
26. Kohonen-Corish MR, Sigglekow ND, Susanto J, Chapuis PH, Bokey EL, et al. (2007) Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Oncogene 26: 4435-4441.
27. Kraunz KS, Nelson HH, Liu M, Wiencke JK, Kelsey KT (2005) Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer. Br J Cancer 93: 949-952.
28. Xing M (2007) BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 28: 742-762.
29. Arimura S, Matsunaga A, Kitamura T, Aoki K, Aoki M, et al. (2009) Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. Gastroenterology 137: 629-638.
30. Zhu J, Woods D, McMahon M, Bishop JM (1998) Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev 12: 2997-3007.
31. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
32. Dankort D, Filenova E, Collado M, Serrano M, Jones K, et al. (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21: 379-384.
33. Mooi WJ, Peeper DS (2006) Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med 355: 1037-1046.
34. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR (2008) Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132: 363-374.
35. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS (2006) CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8: 582-588.
36. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, et al. (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 104: 18654-18659.
37. Schuebel K, Chen W, Baylin SB (2006) CIMPle origin for promoter hypermethylation in colorectal cancer? Nat Genet 38: 738-740.
38. Beach R, Chan AO, Wu TT, White JA, Morris JS, et al. (2005) BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 166: 1069-1075.
39. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, et al. (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30: 1491-1501.
40. Minoo P, Moyer M, Jass J (2007) Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol 212: 124-133.
41. Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, et al. (2008) BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer 8: 255.
42. Muthuswami R, Mesner LD, Wang D, Hill DA, Imbalzano AN, et al. (2000) Phosphoaminoglycosides inhibit SWI2/SNF2 family DNA-dependent molecular motor domains. Biochemistry 39: 4358-4365.
43. Lin J, Lai M, Huang Q, Ma Y, Cui J, et al. (2007) Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression. J Pathol 212: 83-90.
44. Cichowski K, Hahn WC (2008) Unexpected pieces to the senescence puzzle. Cell 133: 958-961.
45. Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, et al. (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300: 949.
46. Bates RC, Goldsmith JD, Bachelder RE, Brown C, Shibuya M, et al. (2003) Flt- 1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Curr Biol 13: 1721-1727.
47. Noren NK, Pasquale EB (2004) Eph receptorephrin bidirectional signals that target Ras and Rho proteins. Cell Signal 16: 655-666.
48. Graells J, Vinyals A, Figueras A, Llorens A, Moreno A, et al. (2004) Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling. J Invest Dermatol 123: 1151-1161.
49. Bellone G, Smirne C, Carbone A, Buffolino A, Scirelli T, et al. (2006) KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes. Int J Oncol 29: 851-859.
50. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
51. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, et al. (1991) Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19: 4293.
52. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, et al. (2005) Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 33: 6823-6836.
53. Suter CM, Norrie M, Ku SL, Cheong KF, Tomlinson I, et al. (2003) CpG island methylation is a common finding in colorectal cancer cell lines. Br J Cancer 88: 413-419.